logo

For the Inventor, By the Inventor

Macclesfield, United Kingdom

Stuart Norman Lile Bennett

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stuart Norman Lile Bennett. Retrieved from https://idiyas.com/inventor/stuart-norman-lile-bennett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.7

ph-index = 1


Location History:

  • Cheshire, GB (2006)
  • Macclesfield, GB (2011 - 2012)

Company Filing History:

goldMedal4 out of 1,534 
 
Astrazeneca Ab
 patents

Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents
1. 8143263 - Therapeutic agents (2012-03-27),
2. 8071608 - Therapeutic agents (2011-12-06),
3. 7138415 - Indolamid derivatives which possess glycogenphosphorylase inhibitory activity (2006-11-21),
4. 7122567 - Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity (2006-10-17),

Title: The Innovations of Stuart Norman Lile Bennett

Introduction

Stuart Norman Lile Bennett is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of therapeutic agents, holding a total of 4 patents. His work focuses on innovative compounds that have the potential to improve medical treatments.

Latest Patents

Among his latest patents, one includes a compound of Formula (I) that is useful in the treatment or prevention of diseases mediated through glucokinase (GLK or GK). This compound leads to a decreased glucose threshold for insulin secretion. Another patent features the compound (2S)-2-[1-(2-Chloro-6-cyano-phenyl)pyrazolo[4,5-e]pyrimidin-4-yl]oxy-3-[(1R)-2-hydroxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)propanamide, which also serves a similar purpose in treating medical conditions related to glucokinase.

Career Highlights

Stuart is currently associated with AstraZeneca Ab, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative therapeutic solutions that address critical health issues.

Collaborations

Throughout his career, Stuart has collaborated with esteemed colleagues such as Rolf Peter Walker and Michael James Waring. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Stuart Norman Lile Bennett's contributions to the field of therapeutic agents highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to addressing significant medical challenges through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…